Enter a Ticker Symbol To Get Your Free Bull/Bear Rating & Ranking Report from "Stock Scientist" Mike Turner

Dividend Quote

ACOR

Acorda Therapeutics Inc

Add to Scorecard

New Report from the Award-winning Analyst Who Beat the Market Over 15 Years

(For Privacy Policy visit us here)
*Note: You will not be spammed, ever. Period.

ACOR:Acorda Therapeutics Inc - Stock Quote and Dividend Data

LATEST CLOSE PRICE

$16.34

EXCHANGE

NASDAQ

SECTOR

Health Care

ACOR
Acorda Therapeutics Inc Dividend Information
Trailing 12 Month Dividend Yield0.00%
Projected 10 Year Dividend Yield0.00%
Dividend Yield 5 Year Average0.00%
Dividend Rate$0.00
Dividend Payout Ratio0.00%
Dividend Payout Ratio 5 yr Average0.00%
Dividend Growth Rate 3 yr Average0.00%
Dividend Growth Rate 5 yr Average0.00%
Dividend AllStar™ Ranking
Consecutive Dividend Increases0 Years

Dividend Payment TypeNone
Dividend Declaration DateNone
Dividend Ex DateNone
Dividend Record DateNone
Dividend Pay DateNone
Dividend Amount Current$0.000
Dividend Amount Previous$0.000
Dividends Paid in the Last 12 Months0
First Dividend PaidNone

FREE INVESTOR BRIEFING

Collect an 8% Yield on this "Government Mandated Income Opportunity"

(For Privacy Policy visit us here)
*Note: You will not be spammed, ever. Period.
ACOR
Acorda Therapeutics Inc Stock Information
Latest Close Price$16.34
52-Week Low/High$15.60 - $36.35
Percent Held by Institutions92.17%
Revenue$733,493,000
Net Income$-160,888,000
Cash Flow$78,172,000
EPS-0.29%
Market Cap$777,097,720
PE Ratio0
PE Ratio to Industry61%
Debt-Equity Ratio57.00%
Debt-Equity to Industry1.39%
Total Return Last 12 Months-22.38%
Total Return Last 3 Years-59.56%
Total Return Last 5 Years-44.67%
Latest Trade DateDec. 17, 2018
ACOR
Acorda Therapeutics Inc Dividend Payment History

No Data available for Payment History.

ACOR
Acorda Therapeutics Inc Other Details

Acorda Therapeutics is a biopharmaceutical company focused on developing therapies for neurological disorders. Co.'s marketed therapies include: Ampyra, an extended release tablet formulation of dalfampridine for the treatment of multiple sclerosis (MS); and Qutenza, a dermal patch for the management of neuropathic pain associated with post-herpetic neuralgia. Co. has a pipeline of neurological therapies addressing a range of disorders, including Parkinson's disease and MS. Co.'s research and development program include SYN120, which is a potential treatment for Parkinson's-related dementia; and BTT1023 (timolumab), a product candidate for the orphan disease Primary Sclerosing Cholangitis.

Web Sitewww.acorda.com
SectorHealth Care
SegmentPharmaceuticals & Biotechnology
IndustryBiotechnology
Dividend AllStar™ Ranking
Dividend Re-Investment PlanNo
Re-Investment AgentNone
Direct Purchase Minimum$0
Optional Cash Pay Min-Max$0 - $0
Optional Cash Payment FrequencyNone
Dividend Tools

Building a successful dividend income portfolio is simple… if you have the right tools at your disposal. Here’s a sampling of Dividend Investor’s Dividend Tools, used by thousands of investors across the globe to gain a substantial edge in their portfolio strategies.

Dividend AllStar™ Ranking

Find stocks with consecutively increasing dividends:

  • = 5 years of dividend increases
  • = 10 years of dividend increases
  • = 20 years of dividend increases

Click to Learn More

Monthly Dividend Directory

Learn which investments pay out every month, including:

  • Dividend yield
  • Ex-dividend date
  • Dividend payout date… and more

Click to Learn More

Stock Screening Tools

Screen and filter thousands of dividend-paying investments with Dividend Investor’s advanced screening tools:

  • Dividend Payout Ratio
  • Consecutive Increases
  • 5-Year Total Return… and more

Click to Learn More

Try Dividend Investor PREMIUM for as low as $29

  • Dividend Allstars™ Tool
  • Proprietary Ex-dividend Calendar
  • Dividend Scorecard™ Portfolio Tracker
  • Customized Dividend Stock Screener
  • 4 FREE special reports from leading dividend experts
  • And much more...
 
Acorda Therapeutics Inc Dividend Stock News and Updates

Dec. 12, 2018CLOSE PRICE DECREASE: Acorda Therapeutics Inc (NASDAQ: ACOR) on 12-12-2018 decreased close price > 10% from $19.03 to $16.16

Read more...

Dec. 05, 2018CLOSE PRICE DECREASE: Acorda Therapeutics Inc (NASDAQ: ACOR) on 12-05-2018 decreased close price > 10% from $20.78 to $18.55

Read more...

Sep. 11, 2018CLOSE PRICE DECREASE: Acorda Therapeutics Inc (NASDAQ: ACOR) on 09-11-2018 decreased close price > 10% from $27.55 to $20.80

Read more...
More Acorda Therapeutics Inc Dividend News
Biotechnology Dividend Stock News and Updates

Dec. 18, 2018CLOSE PRICE DECREASE: Athersys Inc (NASDAQ: ATHX) on 12-18-2018 decreased close price > 10% from $1.92 to $1.72

Read more...

Dec. 18, 2018CLOSE PRICE DECREASE: DNAPrint Genomics Inc. (OTCBB: DNAG) on 12-18-2018 decreased close price > 10% from $0.00 to $0.00

Read more...

Dec. 18, 201852 WEEK LOW: Genenews Ltd (OTCBB: GNWSF) on 12-18-2018 hit a 52 week low of $0.01

Read more...
More Biotechnology Dividend News
FREE REPORT
X
Bryan Perry Dividend Income Expert Bryan Perry

Earn 8% on this "Government Mandated Income Opportunity"

X

Search Dividend Investor